CellImmunologyPeer-reviewed journal article
Enhancing tumor-infiltrating T cells with an exclusive fuel source
Matthew L. Miller, Timothy J. ThaulandiD, Smriti Sameer Nagarajan, Wenqi Ellen Zuo, Miguel A. Moreno Lastre, Manish J. ButteiD
Abstract
Solid tumors harbor immunosuppressive microenvironments that inhibit tumor-infiltrating lymphocytes (TILs) through the voracious consumption of glucose. We sought to restore TIL function by providing them with an exclusive fuel source. The glucose disaccharide cellobiose, which is the building block of cellulose, contains a {beta}-1,4-glycosidic bond that that animals (or their tumors) cannot hydrolyze, but microbes have evolved enzymes to catabolize cellobiose into useful glucose. We equipped mouse T cells and human CAR-T cells with two proteins enabling import and hydrolysis of cellobiose and demonstrated that cellobiose supplementation during glucose withdrawal restores key anti-tumor T-cell functions: viability, proliferation, cytokine production, and cytotoxic killing. Engineered T cells offered cellobiose suppress murine tumor growth and prolong survival. Offering exclusive access to a natural disaccharide is a new tool that augments cancer immunotherapies. This approach could be used to answer questions about glucose metabolism across many cell types, biological processes, and diseases.
- organism: mouse
- organism: human
- assay: proteomics
- assay: metabolomics
- research focus: cancer & tumor microenvironment
- research focus: cell type annotation
- research focus: drug response / drug discovery
- approach: genetic perturbation / CRISPR
- approach: experimental assay
- Citations
- 2
- FWCI
- 5.48
- Field percentile
- top 5%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- GLUT5 armouring enhances adoptive T cell therapy anti-tumour activity under glucose-limiting conditions
Robert Lee Page II, Olivier Martínez, … Esperanza Perucha·Immunotherapy AdvancesPeer-reviewed·Dec 30, 2024
- Inosine is an alternative carbon supply that supports effector T cell proliferation and anti-tumor function under glucose restriction
T. Wang, J. R. Gnanaprakasam, … R. Wang·bioRxiv·Sep 14, 2019
- Lack of Bcl6 promotes anti-tumor immunity by activating glycolysis to rescue CD8 T cell function
Fangkun Luan, Yunqiao Li, … David A. Nemazee·bioRxiv·Apr 1, 2025
- Potentiating the anti-tumor response of tumor infiltrated T cells by NAD+ supplementation
- Glucose-dependent glycosphingolipid biosynthesis fuels CD8+ T cell function and tumor control
Joseph Longo, Lisa M. DeCamp, … Russell G. Jones·Cell MetabolismPeer-reviewed·Aug 5, 2025
- Targeted tumor desialylation by engineered probiotic reprograms the tumor microenvironment to potentiate immunotherapy
Jinhui Wang, Jing Wang, … Wei Ting Xia·bioRxiv·Oct 6, 2026